International Journal of Radiation Oncology * Biology * Physics
Volume 69, Issue 4 , Pages 1209-1217 , 15 November 2007

A Population-based Study of the Fractionation of Palliative Radiotherapy for Bone Metastasis in Ontario

  • Weidong Kong, M.Sc.
  • ,
  • Jina Zhang-Salomons, M.Sc.
  • ,
  • Timothy P. Hanna, M.D.
  • ,
  • William J. Mackillop, M.B.Ch.B., F.R.C.R., F.R.C.P.C.

      Affiliations

    • Corresponding Author InformationReprint requests to: William J. Mackillop, M.B.Ch.B., Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, 10 Stuart Street, Level 2, Kingston, ON K7L 3N6, Canada. Tel: (613) 533-6000, ext. 78509; Fax: (613) 533-6794

Received 10 January 2007 ,Revised 24 April 2007 ,Accepted 30 April 2007.

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics 2006. CA Cancer J Clin. 2006;56:106–130
  2. Portenoy RK, Thaler HT, Kornblith AB, et al. Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res. 1994;3:183–189
  3. Manoso MW, Healey JH. Treatment of metastatic cancer. In:  DeVita VT,  Hellman S,  Rosenberg SA editor. Cancer: Principles & practice of oncology. 7th ed.. Phildelphia: Lippincott Williams & Wilkins; 2004;p. 2368–2381
  4. Sze WM, Shelley MD, Held I, et al. Palliation of metastatic bone pain: Single fraction versus multifraction radiotherapy—A systematic review of randomised trials. Clin Oncol. 2003;15:345–352
  5. Gaze MN, Kelly CG, Kerr GR, et al. Pain relief and quality of life following radiotherapy for bone metastases: A randomised trial of two fractionation schedules. Radiother Oncol. 1997;45:109–116
  6. Hartsell WF, Scott CB, Bruner DW, et al. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst. 2005;97:795–804
  7. van den Hout WB, van der Linden YM, Steenland E, et al. Single versus multiple-fraction radiotherapy in patients with painful bone metastases: Cost-utility analysis based on a randomized trial. J Natl Cancer Inst. 2003;95:222–229
  8. Price P, Hoskin PJ, Easton D, et al. Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol. 1986;6:247–255
  9. Cole DJ. A randomized trial of a single treatment versus conventional fractionation in the palliative radiotherapy of painful bone metastases. Clin Oncol. 1989;1:59–62
  10. Neilsen OS, Bentzen SM, Sandbert E, et al. Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol. 1998;47:233–240
  11. McQuay HJ, Collins SL, Carroll D, et al. Radiotherapy for the palliation of painful bone metastases. Cochrane Database Syst Rev. 2000;2:CD001793
  12. Shakespeare TP, Thiagaraian A, Gebski V. Evaluation of the quality of radiotherapy randomized trials for painful bone metastases. Cancer. 2005;103:1976–1981
  13. Slotman BJ, van der Wal G, Kregar S, et al. Patients' appreciation of single fraction radiotherapy for painful bone metastases. Palliat Med. 2004;18:72–73
  14. Szumacher E, Llewellyn-Thomas H, Franssen E, et al. Treatment of bone metastases with palliative radiotherapy: Patients' treatment preferences. Int J Radiat Oncol Biol Phys. 2005;61:1473–1481
  15. Chow E, Andersson L, Wong R, et al. Patients with advanced cancer: A survey of the understanding of their illness and expectations from palliative radiotherapy for symptomatic metastases. Clin Oncol (R Coll Radiol). 2001;13:204–208
  16. Shakespeare TP, Lu JJ, Back M, et al. Patients' preference for radiotherapy fractionation schedule in the palliation of painful bone metastases. J Clin Oncol. 2003;21:2156–2162
  17. Kachnic L, Berk L. Palliative single-fraction radiation therapy: How much more evidence is needed?. J Natl Cancer Inst. 2005;97:786–788
  18. Priestman T, Bullimore JA, Godden TP, et al. The Royal College of Radiologists' Fractionation Survey. Clin Oncol. 1989;1:39–46
  19. Coia LR, Hanks GE, Martz K, et al. Practice patterns of palliative care for the United States 1984-1985. Int J Radiat Oncol Biol Phys. 1988;14:1261–1269
  20. Duncan G, Duncan W, Maher E. Patterns of palliative radiotherapy in Canada. Clin Oncol. 1993;5:92–97
  21. Ben-Josef E, Shamsa F, Williams AO, et al. Radiotherapeutic management of osseous metastases: A survey of current patterns of care. Int J Radiat Oncol Biol Phys. 1998;40:915–921
  22. Lievens Y, Kesteloot K. Rijnders, et al. Differences in palliative radiotherapy for bone metastases within Western European countries. Radiother Oncol. 2000;556:297–303
  23. Moller TR, Bronsson B, Ceberg J, et al. A prospective survey of radiotherapy practice 2001 in Sweden. Acta Oncologica. 2003;43:387–410
  24. Williams MV, James ND, Summers ET, et al. National survey of radiotherapy fractionation practice in 2003. Clin Oncol. 2006;18:3–14
  25. Haddad P, Wong RKS, Pond GR, et al. Factors influencing the use of single vs multiple fractions of palliative radiotherapy for bone metastases: A 5-year review. Clin Oncol. 2005;17:430–434
  26. Mackillop WJ, Zhou S, Groome PA, et al. Changes in the use of radiotherapy in Ontario 1984-1995. Int J Radiat Oncol Biol Phys. 1999;44:355–362
  27. Mackillop WJ, Fu H, Quirt CF, et al. Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys. 1994;30:221–228
  28. Mackillop WJ, Zhou Y, Quirt CF. A comparison of delays in the treatment of cancer with radiation in Canada and the United States. Int J Radiat Oncol Biol Phys. 1995;32:531–539
  29. Dixon PF, Mackillop WJ. Could changes in clinical practice reduce waiting lists for radiotherapy?. J Health Svcs Res Policy. 2001;6:70–77
  30. Franklin C, Poulsen M. How do waiting times affect radiation dose fractionation schedules?. Radiat Oncol. 2000;44:428–432
  31. Huang J, Zhou S, Groome P, et al. Factors affecting the use of palliative radiotherapy in Ontario. J Clin Oncol. 2001;19:137–144
  32. Clarke EA, Marrett LD, Kreiger N. Cancer registration in Ontario: A computer approach. IARC Sci Publ. 1991;95:246–257
  33. Robles SC, Marrett LD, Clarke EA, et al. An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol. 1988;41:495–501
  34. Mackillop WJ, Zhang-Salomons J, Groome PA, et al. Socioeconomic status and cancer survival in Ontario. J Clin Oncol. 1997;15:1680–1689
  35. McNutt LA, Wu C, Xue X, et al. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003;157:940–943
  36. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702–706
  37. Souchon R. Palliative radiation oncologic therapy: Is patient's age a determining factor of feasibility? A 1-year analysis (1997) at a radiotherapy clinic of an academic teaching hospital. Strahlenther Onkol. 1999;175:218–224
  38. Mitsuhashi N, Hayakawa K, Yamakawa M, et al. Cancer in patients aged 90 years or older: Radiation therapy. Radiology. 1999;211:829–833
  39. Pignon T, Scallier P. Radiotherapy in the elderly. Eur J Surg Oncol. 1998;24:407–411
  40. Tyldesley S, Zhang-Salomons J, Groome PA, et al. Association between age and the utilization of radiotherapy in Ontario. Int J Radiat Oncol Biol Phys. 2000;47:469–480
  41. Wu JS, Wong RK, Lloyd NS, et al. Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases—An evidence-based practice guideline. BMC Cancer. 2004;4:71

 Supported by grants from the Canadian Institutes of Health Research, Cancer Care Ontario, and the Ontario Cancer Research Network (W.J.M.).

 Conflict of interest: none.

PII: S0360-3016(07)00805-X

doi: 10.1016/j.ijrobp.2007.04.048

International Journal of Radiation Oncology * Biology * Physics
Volume 69, Issue 4 , Pages 1209-1217 , 15 November 2007